Results 241 to 250 of about 168,140 (338)

Application of high‐dose‐rate endorectal brachytherapy in the treatment of locally advanced rectal cancer

open access: yesPrecision Radiation Oncology, EarlyView.
This image compares the studies included in this article with the meta‐analysis from the Cochrane Library, indicating that the incorporation of brachytherapy in neoadjuvant treatment for rectal cancer can achieve better pathological response rates. Additionally, the use of brachytherapy can reduce the local recurrence rate in patients.
Tianyao Wang   +6 more
wiley   +1 more source

A phase I–II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer

open access: bronze, 2001
Syed A. Hussain   +5 more
openalex   +1 more source

Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma [PDF]

open access: bronze, 2003
T Noguchi   +6 more
openalex   +1 more source

Dosimetric and hematological toxicity analyses of bone marrow‐sparing intensity‐modulated radiation therapy for patients with cervical cancer treated with extended‐field radiation therapy

open access: yesPrecision Radiation Oncology, EarlyView.
Bone Marrow Sparing Intensity Modulated Radiation Therapy is a feasible option for cervical cancer patients treated with extended‐field radiation therapy, it may reduce hematologic toxicity and ensure the continuity of concurrent chemoradiotherapy. Abstract Objective This study aimed to assess the dosimetric parameters and hematological toxicity (HT ...
Jia‐nan Wang   +10 more
wiley   +1 more source

Complete response of a highly advanced gastric carcinoma to preoperative chemoradiotherapy with S-1 and low-dose cisplatin [PDF]

open access: bronze, 2003
Nobunari Yoshimizu   +8 more
openalex   +1 more source

Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment [PDF]

open access: yes, 2013
Adam   +33 more
core   +1 more source

Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study [PDF]

open access: yes, 2020
Chauhan, Namrata S   +4 more
core   +1 more source

Virtual Clinical Trial Reveals Significant Clinical Potential of Targeting Tumor‐Associated Macrophages and Microglia to Treat Glioblastoma

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Glioblastoma is the most aggressive primary brain tumor, with a median survival of 15 months with treatment. Standard‐of‐care (SOC) consists of resection, radio‐ and chemotherapy. Clinical trials involving PD‐1 inhibition with nivolumab combined with SOC failed to increase survival.
Blanche Mongeon, Morgan Craig
wiley   +1 more source

Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma [PDF]

open access: bronze, 2003
Thomas W. Rice   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy